CD33-CAR T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD33-CAR T cell therapy, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia [Phase 1]